(HealthDay)—In ophthalmology medical malpractice litigation, cases involving pediatric versus adult patients are more likely to result in verdicts in favor of the plaintiff and have higher jury awards and indemnity payments, ...
Sep 6, 2016
0
1
Rockville, Md. Scientists may have overcome a major roadblock in the development of Alzheimer's therapies by creating a new technology to observe—in the back of the eye—progression of the disease before the onset of symptoms. ...
Jul 11, 2016
0
21
An effective vaccine against the virus that causes genital herpes has evaded researchers for decades. But now, researchers from the University of Illinois at Chicago working with scientists from Germany have shown that zinc-oxide ...
Apr 27, 2016
0
204
Researchers from Massachusetts Eye and Ear/Harvard Medical School have identified inflammatory factors that cause optic neuropathy in the back of the eye following implantation of a keratoprosthesis (KPro)—similar to what ...
Apr 7, 2016
0
4
(HealthDay)— Levodopa (L-dopa) might hold potential for preventing or treating macular degeneration, according to a study published online Oct. 30 in The American Journal of Medicine.
Nov 13, 2015
0
9
(HealthDay)—Two novel collagen structures have been revealed by second harmonic generation (SHG) imaging of the human corneal limbus. The findings were published in the September issue of Investigative Ophthalmology & Visual ...
Nov 5, 2015
0
7
Scientists have good news for patients who suffer from currently untreatable dry age-related macular degeneration (dry AMD). In a new study, researchers identified a potential target for future therapies to slow the progression ...
Nov 3, 2015
0
7
Amblyopia, commonly known as "lazy-eye," has been classically treated by patching the strong eye to force the weaker eye to be used. However, the concept of binocular dysfunction, in which the brain suppresses the image from ...
Oct 15, 2015
0
5
The three-year clinical trial results of the retinal implant popularly known as the "bionic eye," have proven the long-term efficacy, safety and reliability of the device that restores vision in those blinded by a rare, degenerative ...
Jun 23, 2015
0
107
After his release Emory University Hospital last October, Dr. Ian Crozier thought his long, near-fatal battle with Ebola was winding down. But less than two months later, he was back at Emory, with an eye that had changed ...
Jun 17, 2015
0
14
